ImmunityBio, Inc.
NASDAQ:IBRX
5.3 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.047 | 0.04 | 0.139 | 0.082 | 0.041 | 0.36 | 0.073 | 0.118 | 0.035 | 0.014 | 0.39 | 0.066 | 0.339 | 0.139 | -0.147 | 0.151 | 0.436 | 0.165 | 0.92 | 0.012 | 0.017 | 0.005 | 0.007 | 0.031 | 0.004 | 0.005 | 0.012 | 0.008 | 0.014 | 0.011 | 0.014 | 0.012 | 0.012 | 0.006 | 0.014 | 0.01 | 0.091 |
Cost of Revenue
| 4.406 | 4.555 | 4.564 | 4.585 | 6.318 | 6.278 | 6.878 | 5.975 | 5.931 | 5.408 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -3.359 | -4.515 | -4.425 | -4.503 | -6.277 | -5.918 | -6.805 | -5.857 | -5.896 | -5.394 | 0.39 | 0.066 | 0.339 | 0.139 | -0.147 | 0.151 | 0.436 | 0.165 | 0.92 | 0.012 | 0.017 | 0.005 | 0.007 | 0.031 | 0.004 | 0.005 | 0.012 | 0.008 | 0.014 | 0.011 | 0.014 | 0.012 | 0.012 | 0.006 | 0.014 | 0.01 | 0.091 |
Gross Profit Ratio
| -3.208 | -112.875 | -31.835 | -54.915 | -153.098 | -16.439 | -93.219 | -49.636 | -168.457 | -385.286 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 51.129 | 52.851 | 51.032 | 48.402 | 53.168 | 79.264 | 58.077 | 71.612 | 63.082 | 55.378 | 51.753 | 49.277 | 53.8 | 41.128 | 43.356 | 35.772 | 33.005 | 27.374 | 13.193 | 12.052 | 13.131 | 12.598 | 12.48 | 14.559 | 14.688 | 13.991 | 12.021 | 11.069 | 9.706 | 9.248 | 9.445 | 8.364 | 6.389 | 4.944 | 5.106 | 3.95 | 1.745 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.326 | 4.025 | 4.182 | 5.742 | 5.246 | 9.58 | 13.594 | 14.298 | 13.385 | 13.381 | 14.128 | 16.227 | 15.713 | 24.423 | 28.588 | 26.651 | 74.831 | 38.854 | 82.429 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 49.251 | 37.83 | 29.046 | 31.816 | 32.018 | 32.676 | 26.215 | 19.31 | 16.575 | 40.608 | 27.911 | 29.625 | 32.445 | 45.275 | 23.882 | 19.596 | 18.347 | 9.493 | 8.526 | 4.025 | 4.182 | 5.742 | 5.246 | 9.58 | 13.594 | 14.298 | 13.385 | 13.381 | 14.128 | 16.227 | 15.713 | 24.423 | 28.588 | 26.651 | 74.831 | 38.854 | 82.429 |
Other Expenses
| -0.017 | -0.02 | -37.023 | 6.47 | -6.796 | -1.077 | -0.923 | 0.006 | 0.185 | -0.004 | -0.059 | -0.038 | 0.277 | 0.013 | 0.217 | 0.084 | 0.081 | 1.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 100.38 | 90.681 | 80.078 | 80.218 | 85.186 | 111.94 | 84.292 | 90.922 | 79.657 | 95.986 | 79.664 | 78.902 | 86.245 | 86.403 | 67.238 | 55.368 | 51.352 | 36.867 | 21.694 | 16.077 | 17.313 | 18.34 | 17.726 | 24.139 | 28.282 | 28.289 | 25.406 | 24.45 | 23.834 | 25.475 | 25.158 | 32.787 | 34.977 | 31.595 | 79.937 | 42.804 | 84.174 |
Operating Income
| -99.333 | -95.196 | -84.503 | -80.136 | -85.145 | -111.58 | -84.9 | -90.804 | -79.622 | -95.972 | -79.274 | -78.836 | -85.906 | -86.264 | -67.385 | -65.877 | -50.916 | -36.702 | -21.357 | -15.576 | -16.68 | -17.918 | -17.323 | -23.614 | -27.749 | -27.61 | -24.625 | -23.675 | -23.422 | -24.576 | -24.35 | -31.92 | -34.225 | -30.793 | -77.123 | -42.649 | -84.581 |
Operating Income Ratio
| -94.874 | -2,379.9 | -607.935 | -977.268 | -2,076.707 | -309.944 | -1,163.014 | -769.525 | -2,274.914 | -6,855.143 | -203.267 | -1,194.485 | -253.41 | -620.604 | 458.401 | -436.272 | -116.78 | -222.436 | -23.214 | -1,298 | -981.176 | -3,583.6 | -2,474.714 | -761.742 | -6,937.25 | -5,522 | -2,052.083 | -2,959.375 | -1,673 | -2,234.182 | -1,739.286 | -2,660 | -2,852.083 | -5,132.167 | -5,508.786 | -4,264.9 | -929.462 |
Total Other Income Expenses Net
| -35.231 | -38.934 | -148.951 | -15.446 | -21.425 | -5.003 | -23.392 | -20.357 | -6.159 | -7.026 | -8.072 | -6.08 | -0.012 | 8.618 | 0.913 | -10.963 | 0.726 | 0.86 | -0.902 | -0.005 | 0.616 | -0.003 | -0.145 | -0.149 | -0.106 | -0.033 | -0.034 | -0.393 | -0.154 | -0.037 | -0.037 | -0.029 | 0.74 | 0.796 | 0 | 0.145 | -0.498 |
Income Before Tax
| -134.564 | -134.13 | -233.454 | -95.582 | -138.213 | -116.583 | -108.292 | -111.161 | -94.835 | -102.998 | -91.552 | -88.429 | -89.383 | -80.475 | -68.782 | -67.87 | -51.972 | -37.409 | -22.259 | -15.581 | -16.68 | -17.921 | -17.468 | -23.763 | -27.855 | -27.643 | -24.659 | -24.068 | -23.576 | -24.613 | -24.387 | -31.949 | -34.225 | -30.793 | -77.123 | -42.649 | -84.581 |
Income Before Tax Ratio
| -128.523 | -3,353.25 | -1,679.525 | -1,165.634 | -3,371.049 | -323.842 | -1,483.452 | -942.042 | -2,709.571 | -7,357 | -234.749 | -1,339.833 | -263.667 | -578.957 | 467.905 | -449.47 | -119.202 | -226.721 | -24.195 | -1,298.417 | -981.176 | -3,584.2 | -2,495.429 | -766.548 | -6,963.75 | -5,528.6 | -2,054.917 | -3,008.5 | -1,684 | -2,237.545 | -1,741.929 | -2,662.417 | -2,852.083 | -5,132.167 | -5,508.786 | -4,264.9 | -929.462 |
Income Tax Expense
| -4.406 | -0.021 | -0.04 | -4.585 | 20.888 | 34.579 | 0.034 | -0.223 | 5.282 | -0.172 | 0.001 | -0.8 | 0.002 | 0.006 | -0.209 | -1.7 | 0.045 | 0.018 | 0.008 | 0.005 | 0.002 | -0.036 | -0.128 | -0.128 | -0.123 | -0.124 | -0.172 | -0.099 | -0.124 | -0.098 | -0.149 | -0.052 | -0.228 | -0.143 | -0.302 | 0.145 | -0.498 |
Net Income
| -134.564 | -134.109 | -233.392 | -95.582 | -137.879 | -151.162 | -108.326 | -110.938 | -94.588 | -102.826 | -91.259 | -87.629 | -88.288 | -79.614 | -67.771 | -65.603 | -51.439 | -37.038 | -22.276 | -15.586 | -16.682 | -17.885 | -17.34 | -23.635 | -27.732 | -27.519 | -24.487 | -23.969 | -23.452 | -24.515 | -24.238 | -31.897 | -33.997 | -30.65 | -76.821 | -42.649 | -84.581 |
Net Income Ratio
| -128.523 | -3,352.725 | -1,679.079 | -1,165.634 | -3,362.902 | -419.894 | -1,483.918 | -940.153 | -2,702.514 | -7,344.714 | -233.997 | -1,327.712 | -260.437 | -572.763 | 461.027 | -434.457 | -117.979 | -224.473 | -24.213 | -1,298.833 | -981.294 | -3,577 | -2,477.143 | -762.419 | -6,933 | -5,503.8 | -2,040.583 | -2,996.125 | -1,675.143 | -2,228.636 | -1,731.286 | -2,658.083 | -2,833.083 | -5,108.333 | -5,487.214 | -4,264.9 | -929.462 |
EPS
| -0.2 | -0.2 | -0.35 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 | -0.18 | -0.17 | -0.13 | -0.097 | -0.067 | -0.04 | -0.042 | -0.055 | -0.053 | -0.075 | -0.088 | -0.087 | -0.078 | -0.075 | -0.072 | -0.075 | -0.074 | -0.097 | -0.1 | -0.094 | -0.24 | -0.14 | -0.27 |
EPS Diluted
| -0.2 | -0.2 | -0.35 | -0.19 | -0.32 | -0.35 | -0.27 | -0.28 | -0.24 | -0.26 | -0.23 | -0.22 | -0.23 | -0.21 | -0.18 | -0.17 | -0.13 | -0.097 | -0.067 | -0.04 | -0.042 | -0.055 | -0.053 | -0.075 | -0.088 | -0.087 | -0.078 | -0.075 | -0.072 | -0.075 | -0.074 | -0.097 | -0.1 | -0.094 | -0.24 | -0.14 | -0.27 |
EBITDA
| -99.333 | -90.641 | -79.939 | -80.136 | -90.884 | -109.789 | -82.928 | -90.511 | -78.703 | -91.836 | -76.463 | -75.12 | -81.556 | -83.165 | -64.8 | -51.424 | -47.044 | -31.86 | -19.903 | -13.374 | -15.098 | -14.899 | -14.536 | -20.838 | -25.38 | -25.987 | -23.056 | -22.214 | -22.048 | -23.414 | -22.511 | -31.15 | -33.712 | -30.308 | -76.718 | -42.624 | -83.592 |
EBITDA Ratio
| -94.874 | -2,266.025 | -575.101 | -977.268 | -2,216.683 | -304.969 | -1,136 | -767.042 | -2,248.657 | -6,559.714 | -196.059 | -1,138.182 | -240.578 | -598.309 | 440.816 | -340.556 | -107.899 | -193.091 | -21.634 | -1,114.5 | -888.118 | -2,979.8 | -2,076.571 | -672.194 | -6,345 | -5,197.4 | -1,921.333 | -2,776.75 | -1,574.857 | -2,128.545 | -1,607.929 | -2,595.833 | -2,809.333 | -5,051.333 | -5,479.857 | -4,262.4 | -918.593 |